Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Infectious Bursal Disease Vaccine (Middle East for Vaccines)
- Development stage
- Unknown
- Lead developer
- MEVAC
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Oral, Ophthalmic, Inhalation
01
Overview
The Infectious Bursal Disease Vaccine developed by Middle East for Vaccines (MEVAC) is a veterinary vaccine designed to protect poultry against Infectious Bursal Disease (IBD), commonly known as Gumboro disease. IBD is a highly contagious viral infection caused by the Infectious Bursal Disease Virus (IBDV), which targets the bursa of Fabricius in young chickens, leading to severe immunosuppression, increased susceptibility to other infections, and high mortality rates. MEVAC's range of IBD vaccines typically includes live-attenuated formulations (such as the Winterfield 2512 strain) and intermediate or intermediate-plus strains tailored to overcome varying levels of maternal antibodies. The vaccine works by inducing an active immune response, providing protective titers to prevent clinical disease and the associated economic losses in commercial poultry production.
- Brand names
- MEVAC GUMBOROMEVAC GUMBORO LMEVAC GUMBORO IMEVAC GUMBORO SYL
- Other names
- Gumboro VaccineIBD VaccineInfectious Bursal Disease Vaccine
Beyond the preview
Go deeper on Infectious Bursal Disease Vaccine (Middle East for Vaccines).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Infectious Bursal Disease Vaccine (Middle East for Vaccines).